PyInvesting

Market research

5P1.F Prim, S.A

F EUR Healthcare

Latest close

12.15 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
208M
P/E ratio
15.91
Analyst target
Not available
Dividend yield
3.3%
Beta
0.51

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Prim, S.A is currently in a long term uptrend where the price is trading 15.5% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.

Prim, S.A's total revenue sank by 11.5% to $37M since the same quarter in the previous year.

Its net income has dropped by 39.7% to $3M since the same quarter in the previous year.

Based on the above factors, Prim, S.A gets an overall score of 2/5.